GMP and Biosafety Aspects in the Production of Recombinant IFN alpha-2a

GMP and Biosafety Aspects in the Production of Recombinant IFN alpha-2a

Bibliographic Details
Main Author:	E. Karl Weibel
Format:	Article
Language:	deu
Published:	Swiss Chemical Society 1994-10-01
Series:	CHIMIA
Online Access:	https://www.chimia.ch/chimia/article/view/2405

Similar Items

Impact of Biosafety on GMP
by: Werner Tosch
Published: (1994-10-01)

Impact of Biosafety on GMP
by: Werner Tosch
Published: (1994-10-01)

Unintended spread of a biosafety level 2 recombinant retrovirus
by: Liffers Sven-T, et al.
Published: (2009-09-01)

A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
by: Le Bon, A, et al.
Published: (2006)

Intracellular production of IFN-alpha 2b in Lactococcus lactis
by: Bayat, Omid, et al.
Published: (2014)

Biosafety management in high-biosafety-risk workshops for vaccine production in China
by: Yu Zhang, et al.
Published: (2023-12-01)

The Effect of Culture Temperature on Recombinant IFN-γ Production and Quality
by: Fox, Steven R., et al.
Published: (2003)

SOME ASPECTS OF CONDUCTING GMP INSPECTIONS IN RUSSIA
by: G. N. Gildeeva, et al.
Published: (2018-03-01)

Advanced biosafety materials for prevention and theranostics of biosafety issues
by: Jianxun Ding, et al.
Published: (2022-04-01)

Biosafety and biosecurity
by: Dongsheng Zhou, et al.
Published: (2019-03-01)

Increased TNF-alpha/IFN-gamma/IL-2 and decreased TNF-alpha/IFN-gamma production by central memory T cells are associated with protective responses against bovine tuberculosis following BCG vaccination
by: Mayara Fernanda Maggioli, et al.
Published: (2016-10-01)

Integration of biosafety surveillance through Biosafety Surveillance Conceptual Data Model
by: Songwang Wang, et al.
Published: (2019-09-01)

On the biosafety of the Russian population
by: Yu. A. Bobylov
Published: (2023-04-01)

Biosafety: The invisible armour
by: Abhiruchi Galhotra, et al.
Published: (2015-01-01)

VIRAL BIOSAFETY OF BIOPHARMACEUTICALS
by: D. A. Gusarov
Published: (2019-01-01)

Biosafety and biological factors
by: Monika Szopa, et al.
Published: (2018-09-01)

Biosafety and biological factors
by: Monika Szopa, et al.
Published: (2018-09-01)

One health in animal production: biosafety and biosecurity issues
by: Mohd Daud, Hassan
Published: (2012)

General biosafety requirements for vaccine production workshops in China
Published: (2021-04-01)

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2
by: Rena A. Mizrahi, et al.
Published: (2022-07-01)

Subcutaneous injection of IFN alpha-2b for COVID-19: an observational study
by: Bo Wang, et al.
Published: (2020-10-01)

SARS-CoV-2 and Biosafety in Laboratory
by: Arwa Al-Shuwaikh, et al.
Published: (2021-06-01)

Biosafety conducts adopted by orthodontists
by: Camila Gonçalves Jezini Monteiro, et al.

Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
by: Sara Moqbil, et al.
Published: (2022-11-01)

Problems of Biosafety in Current International Law
by: A. A. Danalya, et al.
Published: (2022-07-01)

Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic Cells
by: Vikas Duhan, et al.
Published: (2021-01-01)

Biosafety of salmonella in raw vegetables.
by: Nillian, Elexson
Published: (2011)

BIOSAFETY PRINCIPLES IN STOMATOLOGICAL SERVICES
by: Araelis Ramona Ruiz Hernández, et al.
Published: (2013-06-01)

Biosafety materials for tuberculosis treatment
by: Wei Wang, et al.
Published: (2022-08-01)

Overview and prospects of food biosafety
by: Xiaofeng Hu, et al.
Published: (2022-12-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)

Biosafety laboratory risk assessment
by: Na Li, et al.
Published: (2019-09-01)

PERCEPTION OF NURSES ON BIOSAFETY IN THE HOSPITAL
by: Jackeline Kris Santos Moura, et al.
Published: (2012-01-01)

New Frontiers in Biosafety and Biosecurity
by: Alan Raybould
Published: (2021-07-01)

Biosafety of Mesoporous Silica Nanoparticles
by: Estelle Rascol, et al.
Published: (2018-08-01)

PERCEPTION OF NURSES ON BIOSAFETY IN THE HOSPITAL
by: Jackeline Kris Santos Moura, et al.
Published: (2012-01-01)

PERCEPTION OF NURSES ON BIOSAFETY IN THE HOSPITAL
by: Jackeline Kris Santos Moura, et al.
Published: (2012-01-01)

PB1772: HIGH SLIT2 LEVELS ARE ASSOCIATED WITH GMP LIKE AML AND TREATMENT WITH RECOMBINANT SLIT2 INHIBITS LEUKEMOGENESIS
by: Luise Araujo de Albuquerque Simoes, et al.
Published: (2023-08-01)

Biosafety and biosecurity capacity building: insights from implementation of the NUITM-KEMRI biosafety training model
by: Betty Muriithi, et al.
Published: (2018-08-01)

Expression of the recombinant tE2 antigen of bovine viral diarrhea virus (BVDV) in Nicotiana tabacum plants and biosafety studies in mice
by: Melina Laguía, et al.